HONORING A LEGACY
As a medical oncologist specializing in treating breast cancer patients, Dr. Carol Fabian has become an internationally recognized clinician and translational researcher who has led a successful multidisciplinary research team for almost 30 years. Because of her efforts, not only have high-risk women throughout the Midwest had a place to go for advice on individualized cancer risk assessment, genetic testing and standard risk reduction procedures, but they have access to cutting-edge clinical trials focused on prevention interventions with fewer side effects. Dr. Fabian’s collaborations with clinicians, cancer biologists and clinical health psychologists have resulted in multiple peer-reviewed grants and contracts. Additionally, 15 successful clinical trials have been supported by more than $31 million in outside funding, mostly from NCI. More than 5,000 women have been enrolled in breast cancer prevention studies and clinical interventional trials.
HOW YOU CAN HELP
Your donation will be matched dollar for dollar through a generous $2 million challenge gift to establish the Carol J. Fabian Professorship in Breast Cancer Prevention and Survivorship thanks to the Hall Family Foundation. This professorship would honor the work of Dr. Fabian and the continued quest to recruit a top-tier team in translational breast cancer prevention research. It will enable us to build on the legacy of Dr. Fabian and recruit a leading cancer biologist with expertise in breast cancer prevention who will focus on working with clinicians to forge integrated bench to bedside studies.
On behalf of everyone at The University of Kansas Cancer Center, thank you for your consideration of a gift to support our efforts.
***We also want to recognize and thank all donors and partners to date that have supported the establishment of this fund. Because of you, we are on the final stretch to reaching the larger goal of the $2 million challenge grant provided by the Hall Family Foundation.***
To read more about how Dr. Fabian is a Persistent Pioneer in Breast Cancer Research click here.